Novogen Ltd / CanTx Inc. / Australian Securities Exchange / Novogen Group / / /
Event
Product Issues / /
Facility
Pennsylvania Convention Center / Yale University / /
IndustryTerm
main drug technology platforms / candidate product / /
MedicalCondition
tumor / ovarian cancer / cancer / colorectal cancer / neural cancers / neuroblastoma / melanoma / abdominal carcinomatosis / prostate cancer / recurrent ovarian cancer carcinomatosis / glioblastoma / /
Organization
Yale Medical School / Yale / Society of Reproductive Investigation / American Association for Cancer Research / Securities and Exchange Commission / Yale University / /
Person
ASX RELEASE / Gil Mor / Graham Kelly / / /
Position
Chief Operating Officer / Executive Chairman & CEO / Professor / Peter Gunning Non Executive Director / Director Prof Peter Gunning Non / Director John Board of Directors Dr Graham Kelly Chairman & Executive Director Steve Coffey Non Executive / Connor Non Executive Director / /
Microsoft Word[removed]Cantrixil Data Presented at Conferences v2.docx